243 related articles for article (PubMed ID: 18720147)
21. Engineering of solidified glyburide nanocrystals for tablet formulation via loading of carriers: downstream processing, characterization, and bioavailability.
Ali HSM; Hanafy AF; Alqurshi A
Int J Nanomedicine; 2019; 14():1893-1906. PubMed ID: 30936692
[TBL] [Abstract][Full Text] [Related]
22. pH-independent dissolution enhancement for multiple poorly water-soluble drugs by nano-sized solid dispersions based on hydrophobic-hydrophilic conjugates.
Tran CTM; Tran PHL; Tran TTD
Drug Dev Ind Pharm; 2019 Mar; 45(3):514-519. PubMed ID: 30575412
[TBL] [Abstract][Full Text] [Related]
23. Conversion of indomethacin nanosuspensions into solid dosage forms via fluid bed granulation and compaction.
Sahnen F; Kamps JP; Langer K
Eur J Pharm Biopharm; 2020 Sep; 154():89-97. PubMed ID: 32634572
[TBL] [Abstract][Full Text] [Related]
24. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L
Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445
[TBL] [Abstract][Full Text] [Related]
25. Preparation and characterization of freeze-dried 2-methoxyestradiol nanoparticle powders.
Du B; Li XT; Zhao Y; A YM; Zhang ZZ
Pharmazie; 2010 Jul; 65(7):471-6. PubMed ID: 20662313
[TBL] [Abstract][Full Text] [Related]
26. Improved oral bioavailability of core-shell structured beads by redispersion of the shell-forming nanoparticles: preparation, characterization and in vivo studies.
Yao Q; Tao X; Tian B; Tang Y; Shao Y; Kou L; Gou J; Li X; Yin T; Tang X
Colloids Surf B Biointerfaces; 2014 Jan; 113():92-100. PubMed ID: 24060933
[TBL] [Abstract][Full Text] [Related]
27. In Vitro and In Vivo Characterization of Drug Nanoparticles Prepared Using PureNano™ Continuous Crystallizer to Improve the Bioavailability of Poorly Water Soluble Drugs.
Tahara K; Nishikawa M; Matsui K; Hisazumi K; Onodera R; Tozuka Y; Takeuchi H
Pharm Res; 2016 Sep; 33(9):2259-68. PubMed ID: 27301372
[TBL] [Abstract][Full Text] [Related]
28. Insight into the mechanism behind oral bioavailability-enhancement by nanosuspensions through combined dissolution/permeation studies.
Lynnerup JT; Eriksen JB; Bauer-Brandl A; Holsæter AM; Brandl M
Eur J Pharm Sci; 2023 May; 184():106417. PubMed ID: 36870578
[TBL] [Abstract][Full Text] [Related]
29. A potential in situ gel formulation loaded with novel fabricated poly(lactide-co-glycolide) nanoparticles for enhancing and sustaining the ophthalmic delivery of ketoconazole.
Ahmed TA; Aljaeid BM
Int J Nanomedicine; 2017; 12():1863-1875. PubMed ID: 28331311
[TBL] [Abstract][Full Text] [Related]
30. Downstream drug product processing of itraconazole nanosuspension: Factors influencing tablet material properties and dissolution of compacted nanosuspension-layered sugar beads.
Tan EH; Parmentier J; Low A; Möschwitzer JP
Int J Pharm; 2017 Oct; 532(1):131-138. PubMed ID: 28859940
[TBL] [Abstract][Full Text] [Related]
31. Enhanced oral bioavailability of fenofibrate using polymeric nanoparticulated systems: physicochemical characterization and in vivo investigation.
Yousaf AM; Kim DW; Oh YK; Yong CS; Kim JO; Choi HG
Int J Nanomedicine; 2015; 10():1819-30. PubMed ID: 25784807
[TBL] [Abstract][Full Text] [Related]
32. Drug product development and pharmacological evaluation of a sparingly soluble novel camptothecin analog for peroral administration.
Nekkanti V; Karatgi P; Paruchuri S; Pillai R
Drug Deliv; 2011 May; 18(4):294-303. PubMed ID: 21214430
[TBL] [Abstract][Full Text] [Related]
33. Comparison of media milling and microfluidization methods for engineering of nanocrystals: a case study.
Chogale M; Gite S; Patravale V
Drug Dev Ind Pharm; 2020 Nov; 46(11):1763-1775. PubMed ID: 32912040
[TBL] [Abstract][Full Text] [Related]
34. Design of dry nanosuspension with highly spontaneous dispersible characteristics to develop solubilized formulation for poorly water-soluble drugs.
Niwa T; Miura S; Danjo K
Pharm Res; 2011 Sep; 28(9):2339-49. PubMed ID: 21626059
[TBL] [Abstract][Full Text] [Related]
35. Preparation and characterization of an oridonin nanosuspension for solubility and dissolution velocity enhancement.
Gao L; Zhang D; Chen M; Zheng T; Wang S
Drug Dev Ind Pharm; 2007 Dec; 33(12):1332-9. PubMed ID: 18097807
[TBL] [Abstract][Full Text] [Related]
36. Application of spray granulation for conversion of a nanosuspension into a dry powder form.
Bose S; Schenck D; Ghosh I; Hollywood A; Maulit E; Ruegger C
Eur J Pharm Sci; 2012 Aug; 47(1):35-43. PubMed ID: 22565066
[TBL] [Abstract][Full Text] [Related]
37. Comparative study on solid self-nanoemulsifying drug delivery and solid dispersion system for enhanced solubility and bioavailability of ezetimibe.
Rashid R; Kim DW; Yousaf AM; Mustapha O; Fakhar Ud Din ; Park JH; Yong CS; Oh YK; Youn YS; Kim JO; Choi HG
Int J Nanomedicine; 2015; 10():6147-59. PubMed ID: 26491288
[TBL] [Abstract][Full Text] [Related]
38. Understanding a relaxation behavior in a nanoparticle suspension for drug delivery applications.
Deng Z; Xu S; Li S
Int J Pharm; 2008 Mar; 351(1-2):236-43. PubMed ID: 18093763
[TBL] [Abstract][Full Text] [Related]
39. Spray drying of a poorly water-soluble drug nanosuspension for tablet preparation: formulation and process optimization with bioavailability evaluation.
Sun W; Ni R; Zhang X; Li LC; Mao S
Drug Dev Ind Pharm; 2015 Jun; 41(6):927-33. PubMed ID: 24785575
[TBL] [Abstract][Full Text] [Related]
40. Fabrication of drug nanoparticles by evaporative precipitation of nanosuspension.
Kakran M; Sahoo NG; Li L; Judeh Z; Wang Y; Chong K; Loh L
Int J Pharm; 2010 Jan; 383(1-2):285-92. PubMed ID: 19781606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
